The Paradigm Shift from Traditional Scientific Platforms to Integrated Communications Plans
In the rapidly evolving biopharma landscape, the approach to scientific communications is undergoing a significant transformation. The shift from traditional scientific platforms to integrated communications plans (ICPs) is becoming increasingly crucial for ensuring cohesive and impactful messaging. This article delves into the components, implementation, and benefits of an ICP tailored for the biopharma industry, addressing the challenges of fragmented messaging and the need for a unified communication strategy...
Read MoreTop Stories
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Celebrating Health Literacy Month 2024:
October is Health Literacy Month, a reminder of the...
Filter
3 Factors That Will Help Pharma Build Public Trust
Pharma must engage with patients at all levels to build public trust...
Reel Your Audience in with a Visual Abstract
Graphical abstracts allow room for science communication to be reimagined in a range of creative...
Role of Scientific Communication and Medical Professionals in Combating Vaccine Hesitancy
Read an insightful discussion from the latest ISMPP conference on how science communication and medical...
How Academic Societies Are Embracing the New Digital World: A Look at the Years Gone by and Ahead
The pandemic has required traditional academic societies to rapidly pivot to digital formats for conferences...
Preprints, MedRxiv, and Pharma – An Overview
Non-peer reviewed and unpublished manuscripts, aka preprints, are slowly being embraced by the pharma industry...
Digital Therapeutics and Medical Communications: Are We Ready?
Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...